Eau Thermale Avène is celebrating its 30th anniversary this year.
A leading dermo-cosmetic player sold through pharmacies in over 130 countries, including Australia, the brand’s parent company Pierre Fabre is owned by a not-for-profit foundation and is dedicated to further research to provide dermatological benefits to the global skincare market.
To re-focus its investments on core brands, including Avène, Klorane, A-Derma, Rene Furterer and Ducray, Pierre Fabre is selling the Elancyl and Galenic body and skincare brands.
Elancyl pioneered the anti-cellulite market and is sold in 20 countries, notably France, Spain, Greece, Portugal and Poland.
With sales of AUD$16.26 million in 2019, the brand has been acquired by Cantabria Labs, the leading Spanish pharmaceutical company who own key skincare brands in Brazil, Italy and Belgium and distribute NeoStrata and Dr Obagi products in Spain. The goal is to expand the Elancyl brand internationally.
Yatsen, the four year old Chinese direct-to-consumer company, who own the popular Perfect Diary, Little Ondine and Abby’s Choice makeup and skincare brands, have bought the Galenic luxury skincare brand founded by Pierre Fabre in 1977.
More than 20 million consumers in China have bought Yatsen products and the company will launch Galenic in China and continue to strongly market the brand in Europe.
Pierre Fabre had a global turnover of AUD$3.98 billion in 2019 and will retain a 10 per cent minority share in the European operations of Galenic.
Yatsen filed for an IPO in the US late last week to become the first Chinese beauty company to list on the New York Stock Exchange. The offering hopes to raise US$100 million, backed by revenues of US$453.7 million in 2019.